With reference to the earlier letter dated January 28, 2016 informing that a Meeting of the Board of Directors of the Company will be held on February 09, 2016 to consider the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2015. Aurobindo Pharma has now informed that at the Board Meeting to be held on February 09, 2016, the Board will also consider the proposal of payment of Third Interim Dividend for the year 2015-16.
The above information is a part of company’s filings submitted to BSE.
